Devraj Chavda
Neurology with Special Qualifications in Child Neurology · Las Vegas, NVNPI 1558814889
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,496 of the $7,369 with a category attached, or 88.2%. 35 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 24.6% of the total. 2025 is the largest year on record at $2,997, 8.2 times the $365 reported in 2022.
Across 225 payments — averaging $32.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$2K
- UCB, Inc.$1K
- NS Pharma, Inc.$440
- Acadia Pharmaceuticals Inc$427
- Livanova USA, Inc.$374
- SK Life Science, Inc.$336
- plus $3K from 29 others
What the payments were for
- Travel & lodging$87212%
- Food & beverage$6,49688%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 24 | $1,814 |
| UCB, Inc. | 38 | $1,189 |
| NS Pharma, Inc. | 11 | $440 |
| Acadia Pharmaceuticals Inc | 20 | $427 |
| Livanova USA, Inc. | 7 | $374 |
| SK Life Science, Inc. | 8 | $336 |
| Sarepta Therapeutics, Inc. | 9 | $294 |
| Biogen | 11 | $259 |
| Catalyst Pharmaceuticals, Inc. | 13 | $257 |
| Neurelis, Inc. | 10 | $239 |
| ITF Therapeutics LLC | 12 | $228 |
| PTC Therapeutics, Inc. | 9 | $224 |
| Genentech USA, Inc. | 8 | $209 |
| Biocodex, Inc. | 6 | $177 |
| Immedica Pharma US, Inc. | 3 | $106 |
| Upsher-smith Laboratories LLC | 4 | $102 |
| Ipsen Biopharmaceuticals, Inc | 3 | $80 |
| Ironshore Pharmaceuticals Inc. | 3 | $78 |
| Pyros Pharmaceuticals, Inc. | 2 | $75 |
| AstraZeneca | 3 | $67 |
| Novartis | 2 | $51 |
| Eisai Inc. | 3 | $48 |
| Aquestive Therapeutics, Inc. | 2 | $45 |
| Amneal Pharmaceuticals LLC | 2 | $32 |
| Intrabio Inc | 1 | $29 |
| Springworks Therapeutics, Inc. | 1 | $26 |
| Azurity Pharmaceuticals, Inc. | 1 | $22 |
| Pfizer | 1 | $22 |
| Sunovion Pharmaceuticals Inc. | 1 | $22 |
| Nobelpharma America, LLC | 1 | $21 |
| Cranial Technologies, Inc | 1 | $21 |
| Aucta Pharmaceuticals, Inc. | 2 | $21 |
| Biomarin Pharmaceutical Inc. | 1 | $18 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $16 |
| Travere Therapeutics, Inc. | 1 | $1 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Epidiolex$1,198
- VILTEPSO$189
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$164
- Briviact$124
- Fintepla$105
How this compares
Too few neurology with special qualifications in child neurology providers in Nevadato place this figure against a meaningful peer group, so we don't.
Other neurology with special qualifications in child neurology in Las Vegas
- Mei JiangLas Vegas$4K
- Rooman AhadLas Vegas$2K
- Gerardo RodriguezReno$11K
- Colin NguyenReno$4K
- Roshan RajaHenderson$4K
- Stacey KnoblerReno$3K
- Herbert EzughaHenderson$3K
- Monica ChaconHenderson$2K
- Tiffani McDonoughReno$286
- Shanti ThirumalaiReno$226
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.